Metabolomics Workbench : NIH Data Repository

Samples for study ST002354

Species: Rattus norvegicus (Factor headings shown in green)

mb_sample_id	Subject name	Sample name	Genotype	Sample_Data:RAW_FILE_NAME
SA236514	2168	EicoP10	F344 Pirc \| Treatment:200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP10.wiff
SA236515	2333	EicoP11	F344 Pirc \| Treatment:200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP11.wiff
SA236518	2444	EicoP12	F344 Pirc \| Treatment:200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP12.wiff
SA236517	2445	EicoP13	F344 Pirc \| Treatment:200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP13.wiff
SA236516	2853	EicoP14	F344 Pirc \| Treatment:200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP14.wiff
SA236512	2165	EicoP8	F344 Pirc \| Treatment:200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP8.wiff
SA236513	2167	EicoP9	F344 Pirc \| Treatment:200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP9.wiff
SA236525	2336	EicoT10	F344 Pirc \| Treatment:200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT10.wiff
SA236522	2850	EicoT11	F344 Pirc \| Treatment:200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT11.wiff
SA236521	2853	EicoT12	F344 Pirc \| Treatment:200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT12.wiff
SA236519	2853	EicoT13	F344 Pirc \| Treatment:200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT13.wiff
SA236520	3099	EicoT14	F344 Pirc \| Treatment:200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT14.wiff
SA236523	2445	EicoT8	F344 Pirc \| Treatment:200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT8.wiff
SA236524	2446	EicoT9	F344 Pirc \| Treatment:200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT9.wiff
SA236528	2168	TFA-P10	F344 Pirc \| Treatment:200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P10.wiff
SA236526	2333	TFA-P11	F344 Pirc \| Treatment:200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P11.wiff
SA236527	2444	TFA-P12	F344 Pirc \| Treatment:200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P12.wiff
SA236532	2445	TFA-P13	F344 Pirc \| Treatment:200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P13.wiff
SA236530	2853	TFA-P14	F344 Pirc \| Treatment:200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P14.wiff
SA236529	2165	TFA-P8	F344 Pirc \| Treatment:200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P8.wiff
SA236531	2167	TFA-P9	F344 Pirc \| Treatment:200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P9.wiff
SA236535	2336	TFA-T10	F344 Pirc \| Treatment:200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T10.wiff
SA236533	2850	TFA-T11	F344 Pirc \| Treatment:200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T11.wiff
SA236536	2853	TFA-T12	F344 Pirc \| Treatment:200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T12.wiff
SA236537	2853	TFA-T13	F344 Pirc \| Treatment:200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T13.wiff
SA236534	3099	TFA-T14	F344 Pirc \| Treatment:200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T14.wiff
SA236539	2445	TFA-T8	F344 Pirc \| Treatment:200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T8.wiff
SA236538	2446	TFA-T9	F344 Pirc \| Treatment:200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T9.wiff
SA236540	2538	EicoP1	F344 Pirc \| Treatment:AIN-93G (control) \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP1.wiff
SA236542	2547	EicoP2	F344 Pirc \| Treatment:AIN-93G (control) \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP2.wiff
SA236543	2442	EicoP3	F344 Pirc \| Treatment:AIN-93G (control) \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP3.wiff
SA236544	2440	EicoP4	F344 Pirc \| Treatment:AIN-93G (control) \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP4.wiff
SA236545	3183	EicoP5	F344 Pirc \| Treatment:AIN-93G (control) \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP5.wiff
SA236541	3181	EicoP6	F344 Pirc \| Treatment:AIN-93G (control) \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP6.wiff
SA236546	3190	EicoP7	F344 Pirc \| Treatment:AIN-93G (control) \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP7.wiff
SA236549	2440	EicoT1	F344 Pirc \| Treatment:AIN-93G (control) \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT1.wiff
SA236548	2443	EicoT2	F344 Pirc \| Treatment:AIN-93G (control) \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT2.wiff
SA236550	2538	EicoT3	F344 Pirc \| Treatment:AIN-93G (control) \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT3.wiff
SA236547	2547	EicoT4	F344 Pirc \| Treatment:AIN-93G (control) \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT4.wiff
SA236552	3181	EicoT5	F344 Pirc \| Treatment:AIN-93G (control) \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT5.wiff
SA236553	3183	EicoT6	F344 Pirc \| Treatment:AIN-93G (control) \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT6.wiff
SA236551	2444	EicoT7	F344 Pirc \| Treatment:AIN-93G (control) \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT7.wiff
SA236560	2538	TFA-P1	F344 Pirc \| Treatment:AIN-93G (control) \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P1.wiff
SA236554	2547	TFA-P2	F344 Pirc \| Treatment:AIN-93G (control) \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P2.wiff
SA236559	2442	TFA-P3	F344 Pirc \| Treatment:AIN-93G (control) \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P3.wiff
SA236558	2440	TFA-P4	F344 Pirc \| Treatment:AIN-93G (control) \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P4.wiff
SA236557	3183	TFA-P5	F344 Pirc \| Treatment:AIN-93G (control) \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P5.wiff
SA236556	3181	TFA-P6	F344 Pirc \| Treatment:AIN-93G (control) \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P6.wiff
SA236555	3190	TFA-P7	F344 Pirc \| Treatment:AIN-93G (control) \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P7.wiff
SA236561	2440	TFA-T1	F344 Pirc \| Treatment:AIN-93G (control) \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T1.wiff
SA236562	2443	TFA-T2	F344 Pirc \| Treatment:AIN-93G (control) \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T2.wiff
SA236563	2538	TFA-T3	F344 Pirc \| Treatment:AIN-93G (control) \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T3.wiff
SA236564	2547	TFA-T4	F344 Pirc \| Treatment:AIN-93G (control) \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T4.wiff
SA236567	3181	TFA-T5	F344 Pirc \| Treatment:AIN-93G (control) \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T5.wiff
SA236565	3183	TFA-T6	F344 Pirc \| Treatment:AIN-93G (control) \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T6.wiff
SA236566	2444	TFA-T7	F344 Pirc \| Treatment:AIN-93G (control) \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T7.wiff
SA236596	2177	EicoP50	F344 Pirc \| Treatment:EPA-FFA (2%) + 200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP50.wiff
SA236599	2180	EicoP51	F344 Pirc \| Treatment:EPA-FFA (2%) + 200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP51.wiff
SA236598	2384	EicoP52	F344 Pirc \| Treatment:EPA-FFA (2%) + 200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP52.wiff
SA236600	2389	EicoP53	F344 Pirc \| Treatment:EPA-FFA (2%) + 200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP53.wiff
SA236602	2391	EicoP54	F344 Pirc \| Treatment:EPA-FFA (2%) + 200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP54.wiff
SA236601	2744	EicoP55	F344 Pirc \| Treatment:EPA-FFA (2%) + 200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP55.wiff
SA236597	2745	EicoP56	F344 Pirc \| Treatment:EPA-FFA (2%) + 200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP56.wiff
SA236606	3102	EicoT50	F344 Pirc \| Treatment:EPA-FFA (2%) + 200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT50.wiff
SA236609	3104	EicoT51	F344 Pirc \| Treatment:EPA-FFA (2%) + 200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT51.wiff
SA236608	2744	EicoT52	F344 Pirc \| Treatment:EPA-FFA (2%) + 200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT52.wiff
SA236605	2745	EicoT53	F344 Pirc \| Treatment:EPA-FFA (2%) + 200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT53.wiff
SA236607	2844	EicoT54	F344 Pirc \| Treatment:EPA-FFA (2%) + 200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT54.wiff
SA236604	2845	EicoT55	F344 Pirc \| Treatment:EPA-FFA (2%) + 200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT55.wiff
SA236603	2846	EicoT56	F344 Pirc \| Treatment:EPA-FFA (2%) + 200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT56.wiff
SA236611	2177	TFA-P50	F344 Pirc \| Treatment:EPA-FFA (2%) + 200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P50.wiff
SA236610	2180	TFA-P51	F344 Pirc \| Treatment:EPA-FFA (2%) + 200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P51.wiff
SA236612	2384	TFA-P52	F344 Pirc \| Treatment:EPA-FFA (2%) + 200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P52.wiff
SA236613	2389	TFA-P53	F344 Pirc \| Treatment:EPA-FFA (2%) + 200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P53.wiff
SA236614	2391	TFA-P54	F344 Pirc \| Treatment:EPA-FFA (2%) + 200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P54.wiff
SA236615	2744	TFA-P55	F344 Pirc \| Treatment:EPA-FFA (2%) + 200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P55.wiff
SA236616	2745	TFA-P56	F344 Pirc \| Treatment:EPA-FFA (2%) + 200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P56.wiff
SA236617	3102	TFA-T50	F344 Pirc \| Treatment:EPA-FFA (2%) + 200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T50.wiff
SA236619	3104	TFA-T51	F344 Pirc \| Treatment:EPA-FFA (2%) + 200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T51.wiff
SA236618	2744	TFA-T52	F344 Pirc \| Treatment:EPA-FFA (2%) + 200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T52.wiff
SA236621	2745	TFA-T53	F344 Pirc \| Treatment:EPA-FFA (2%) + 200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T53.wiff
SA236623	2844	TFA-T54	F344 Pirc \| Treatment:EPA-FFA (2%) + 200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T54.wiff
SA236622	2845	TFA-T55	F344 Pirc \| Treatment:EPA-FFA (2%) + 200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T55.wiff
SA236620	2846	TFA-T56	F344 Pirc \| Treatment:EPA-FFA (2%) + 200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T56.wiff
SA236571	2385	EicoP43	F344 Pirc \| Treatment:EPA-FFA (2% EPA) \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP43.wiff
SA236572	2394	EicoP44	F344 Pirc \| Treatment:EPA-FFA (2% EPA) \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP44.wiff
SA236569	2398	EicoP45	F344 Pirc \| Treatment:EPA-FFA (2% EPA) \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP45.wiff
SA236568	2738	EicoP46	F344 Pirc \| Treatment:EPA-FFA (2% EPA) \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP46.wiff
SA236570	2741	EicoP47	F344 Pirc \| Treatment:EPA-FFA (2% EPA) \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP47.wiff
SA236574	2847	EicoP48	F344 Pirc \| Treatment:EPA-FFA (2% EPA) \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP48.wiff
SA236573	2852	EicoP49	F344 Pirc \| Treatment:EPA-FFA (2% EPA) \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP49.wiff
SA236580	2738	EicoT43	F344 Pirc \| Treatment:EPA-FFA (2% EPA) \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT43.wiff
SA236579	2741	EicoT44	F344 Pirc \| Treatment:EPA-FFA (2% EPA) \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT44.wiff
SA236578	2847	EicoT45	F344 Pirc \| Treatment:EPA-FFA (2% EPA) \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT45.wiff
SA236577	2852	EicoT46	F344 Pirc \| Treatment:EPA-FFA (2% EPA) \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT46.wiff
SA236581	2854	EicoT47	F344 Pirc \| Treatment:EPA-FFA (2% EPA) \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT47.wiff
SA236575	3024	EicoT48	F344 Pirc \| Treatment:EPA-FFA (2% EPA) \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT48.wiff
SA236576	2385	EicoT49	F344 Pirc \| Treatment:EPA-FFA (2% EPA) \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT49.wiff
SA236586	2385	TFA-P43	F344 Pirc \| Treatment:EPA-FFA (2% EPA) \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P43.wiff
SA236583	2394	TFA-P44	F344 Pirc \| Treatment:EPA-FFA (2% EPA) \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P44.wiff
SA236587	2398	TFA-P45	F344 Pirc \| Treatment:EPA-FFA (2% EPA) \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P45.wiff
SA236588	2738	TFA-P46	F344 Pirc \| Treatment:EPA-FFA (2% EPA) \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P46.wiff
SA236584	2741	TFA-P47	F344 Pirc \| Treatment:EPA-FFA (2% EPA) \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P47.wiff
SA236582	2847	TFA-P48	F344 Pirc \| Treatment:EPA-FFA (2% EPA) \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P48.wiff
SA236585	2852	TFA-P49	F344 Pirc \| Treatment:EPA-FFA (2% EPA) \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P49.wiff
SA236593	2738	TFA-T43	F344 Pirc \| Treatment:EPA-FFA (2% EPA) \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T43.wiff
SA236589	2741	TFA-T44	F344 Pirc \| Treatment:EPA-FFA (2% EPA) \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T44.wiff
SA236591	2847	TFA-T45	F344 Pirc \| Treatment:EPA-FFA (2% EPA) \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T45.wiff
SA236590	2852	TFA-T46	F344 Pirc \| Treatment:EPA-FFA (2% EPA) \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T46.wiff
SA236592	2854	TFA-T47	F344 Pirc \| Treatment:EPA-FFA (2% EPA) \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T47.wiff
SA236594	3024	TFA-T48	F344 Pirc \| Treatment:EPA-FFA (2% EPA) \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T48.wiff
SA236595	2385	TFA-T49	F344 Pirc \| Treatment:EPA-FFA (2% EPA) \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T49.wiff
SA236627	2171	EicoP36	F344 Pirc \| Treatment:HD TP-252 (3% EPA) + 200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP36.wiff
SA236624	2174	EicoP37	F344 Pirc \| Treatment:HD TP-252 (3% EPA) + 200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP37.wiff
SA236628	2175	EicoP38	F344 Pirc \| Treatment:HD TP-252 (3% EPA) + 200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP38.wiff
SA236625	2386	EicoP39	F344 Pirc \| Treatment:HD TP-252 (3% EPA) + 200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP39.wiff
SA236626	2387	EicoP40	F344 Pirc \| Treatment:HD TP-252 (3% EPA) + 200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP40.wiff
SA236630	2900	EicoP41	F344 Pirc \| Treatment:HD TP-252 (3% EPA) + 200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP41.wiff
SA236629	2743	EicoP42	F344 Pirc \| Treatment:HD TP-252 (3% EPA) + 200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP42.wiff
SA236634	2386	EicoT36	F344 Pirc \| Treatment:HD TP-252 (3% EPA) + 200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT36.wiff
SA236633	2743	EicoT37	F344 Pirc \| Treatment:HD TP-252 (3% EPA) + 200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT37.wiff
SA236636	2747	EicoT38	F344 Pirc \| Treatment:HD TP-252 (3% EPA) + 200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT38.wiff
SA236632	2899	EicoT39	F344 Pirc \| Treatment:HD TP-252 (3% EPA) + 200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT39.wiff
SA236631	2900	EicoT40	F344 Pirc \| Treatment:HD TP-252 (3% EPA) + 200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT40.wiff
SA236637	3029	EicoT41	F344 Pirc \| Treatment:HD TP-252 (3% EPA) + 200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT41.wiff
SA236635	3030	EicoT42	F344 Pirc \| Treatment:HD TP-252 (3% EPA) + 200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT42.wiff
SA236640	2171	TFA-P36	F344 Pirc \| Treatment:HD TP-252 (3% EPA) + 200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P36.wiff
SA236639	2174	TFA-P37	F344 Pirc \| Treatment:HD TP-252 (3% EPA) + 200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P37.wiff
SA236642	2175	TFA-P38	F344 Pirc \| Treatment:HD TP-252 (3% EPA) + 200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P38.wiff
SA236638	2386	TFA-P39	F344 Pirc \| Treatment:HD TP-252 (3% EPA) + 200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P39.wiff
SA236641	2387	TFA-P40	F344 Pirc \| Treatment:HD TP-252 (3% EPA) + 200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P40.wiff
SA236643	2900	TFA-P41	F344 Pirc \| Treatment:HD TP-252 (3% EPA) + 200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P41.wiff
SA236644	2743	TFA-P42	F344 Pirc \| Treatment:HD TP-252 (3% EPA) + 200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P42.wiff
SA236651	2386	TFA-T36	F344 Pirc \| Treatment:HD TP-252 (3% EPA) + 200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T36.wiff
SA236649	2743	TFA-T37	F344 Pirc \| Treatment:HD TP-252 (3% EPA) + 200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T37.wiff
SA236648	2747	TFA-T38	F344 Pirc \| Treatment:HD TP-252 (3% EPA) + 200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T38.wiff
SA236650	2899	TFA-T39	F344 Pirc \| Treatment:HD TP-252 (3% EPA) + 200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T39.wiff
SA236647	2900	TFA-T40	F344 Pirc \| Treatment:HD TP-252 (3% EPA) + 200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T40.wiff
SA236645	3029	TFA-T41	F344 Pirc \| Treatment:HD TP-252 (3% EPA) + 200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T41.wiff
SA236646	3030	TFA-T42	F344 Pirc \| Treatment:HD TP-252 (3% EPA) + 200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T42.wiff
SA236654	2170	EicoP22	F344 Pirc \| Treatment:HD TP-252 (3% EPA) \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP22.wiff
SA236653	2169	EicoP23	F344 Pirc \| Treatment:HD TP-252 (3% EPA) \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP23.wiff
SA236656	2271	EicoP24	F344 Pirc \| Treatment:HD TP-252 (3% EPA) \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP24.wiff
SA236652	2451	EicoP25	F344 Pirc \| Treatment:HD TP-252 (3% EPA) \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP25.wiff
SA236655	2453	EicoP26	F344 Pirc \| Treatment:HD TP-252 (3% EPA) \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP26.wiff
SA236657	2284	EicoP27	F344 Pirc \| Treatment:HD TP-252 (3% EPA) \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP27.wiff
SA236658	2282	EicoP28	F344 Pirc \| Treatment:HD TP-252 (3% EPA) \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP28.wiff
SA236660	2451	EicoT22	F344 Pirc \| Treatment:HD TP-252 (3% EPA) \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT22.wiff
SA236659	2453	EicoT23	F344 Pirc \| Treatment:HD TP-252 (3% EPA) \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT23.wiff
SA236661	2454	EicoT24	F344 Pirc \| Treatment:HD TP-252 (3% EPA) \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT24.wiff
SA236665	2884	EicoT25	F344 Pirc \| Treatment:HD TP-252 (3% EPA) \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT25.wiff
SA236662	2885	EicoT26	F344 Pirc \| Treatment:HD TP-252 (3% EPA) \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT26.wiff
SA236664	2271	EicoT27	F344 Pirc \| Treatment:HD TP-252 (3% EPA) \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT27.wiff
SA236663	2282	EicoT28	F344 Pirc \| Treatment:HD TP-252 (3% EPA) \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT28.wiff
SA236670	2170	TFA-P22	F344 Pirc \| Treatment:HD TP-252 (3% EPA) \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P22.wiff
SA236671	2169	TFA-P23	F344 Pirc \| Treatment:HD TP-252 (3% EPA) \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P23.wiff
SA236669	2271	TFA-P24	F344 Pirc \| Treatment:HD TP-252 (3% EPA) \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P24.wiff
SA236667	2451	TFA-P25	F344 Pirc \| Treatment:HD TP-252 (3% EPA) \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P25.wiff
SA236666	2453	TFA-P26	F344 Pirc \| Treatment:HD TP-252 (3% EPA) \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P26.wiff
SA236668	2284	TFA-P27	F344 Pirc \| Treatment:HD TP-252 (3% EPA) \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P27.wiff
SA236672	2282	TFA-P28	F344 Pirc \| Treatment:HD TP-252 (3% EPA) \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P28.wiff
SA236678	2451	TFA-T22	F344 Pirc \| Treatment:HD TP-252 (3% EPA) \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T22.wiff
SA236677	2453	TFA-T23	F344 Pirc \| Treatment:HD TP-252 (3% EPA) \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T23.wiff
SA236675	2454	TFA-T24	F344 Pirc \| Treatment:HD TP-252 (3% EPA) \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T24.wiff
SA236676	2884	TFA-T25	F344 Pirc \| Treatment:HD TP-252 (3% EPA) \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T25.wiff
SA236679	2885	TFA-T26	F344 Pirc \| Treatment:HD TP-252 (3% EPA) \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T26.wiff
SA236673	2271	TFA-T27	F344 Pirc \| Treatment:HD TP-252 (3% EPA) \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T27.wiff
SA236674	2282	TFA-T28	F344 Pirc \| Treatment:HD TP-252 (3% EPA) \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T28.wiff
SA236685	2344	EicoP29	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) + 200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP29.wiff
SA236681	2458	EicoP30	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) + 200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP30.wiff
SA236686	2352	EicoP31	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) + 200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP31.wiff
SA236683	2460	EicoP32	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) + 200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP32.wiff
SA236684	2879	EicoP33	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) + 200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP33.wiff
SA236680	2883	EicoP34	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) + 200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP34.wiff
SA236682	2463	EicoP35	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) + 200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP35.wiff
SA236692	2344	EicoT29	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) + 200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT29.wiff
SA236691	2458	EicoT30	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) + 200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT30.wiff
SA236690	2460	EicoT31	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) + 200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT31.wiff
SA236688	2463	EicoT32	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) + 200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT32.wiff
SA236689	2878	EicoT33	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) + 200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT33.wiff
SA236693	2879	EicoT34	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) + 200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT34.wiff
SA236687	2883	EicoT35	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) + 200 ppm Naproxen \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT35.wiff
SA236699	2344	TFA-P29	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) + 200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P29.wiff
SA236695	2458	TFA-P30	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) + 200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P30.wiff
SA236696	2352	TFA-P31	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) + 200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P31.wiff
SA236697	2460	TFA-P32	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) + 200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P32.wiff
SA236698	2879	TFA-P33	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) + 200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P33.wiff
SA236700	2883	TFA-P34	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) + 200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P34.wiff
SA236694	2463	TFA-P35	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) + 200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P35.wiff
SA236701	2344	TFA-T29	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) + 200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T29.wiff
SA236707	2458	TFA-T30	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) + 200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T30.wiff
SA236706	2460	TFA-T31	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) + 200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T31.wiff
SA236705	2463	TFA-T32	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) + 200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T32.wiff
SA236704	2878	TFA-T33	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) + 200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T33.wiff
SA236702	2879	TFA-T34	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) + 200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T34.wiff
SA236703	2883	TFA-T35	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) + 200 ppm Naproxen \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T35.wiff
SA236709	2264	EicoP15	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP15.wiff
SA236708	2267	EicoP16	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP16.wiff
SA236712	2265	EicoP17	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP17.wiff
SA236711	2448	EicoP18	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP18.wiff
SA236713	2449	EicoP19	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP19.wiff
SA236714	2450	EicoP20	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP20.wiff
SA236710	3020	EicoP21	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) \| Metabolite:Eicosanoid \| Tissue:Plasma	EicoP21.wiff
SA236716	2448	EicoT15	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT15.wiff
SA236715	2449	EicoT16	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT16.wiff
SA236717	2450	EicoT17	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT17.wiff
SA236721	2901	EicoT18	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT18.wiff
SA236720	2903	EicoT19	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT19.wiff
SA236719	3020	EicoT20	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT20.wiff
SA236718	3021	EicoT21	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) \| Metabolite:Eicosanoid \| Tissue:Tumor-adjacent normal colon	EicoT21.wiff
SA236724	2264	TFA-P15	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P15.wiff
SA236722	2267	TFA-P16	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P16.wiff
SA236728	2265	TFA-P17	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P17.wiff
SA236727	2448	TFA-P18	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P18.wiff
SA236725	2449	TFA-P19	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P19.wiff
SA236726	2450	TFA-P20	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P20.wiff
SA236723	3020	TFA-P21	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) \| Metabolite:Fatty Acid \| Tissue:Plasma	TFA-P21.wiff
SA236732	2448	TFA-T15	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T15.wiff
SA236733	2449	TFA-T16	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T16.wiff
SA236734	2450	TFA-T17	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T17.wiff
SA236735	2901	TFA-T18	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T18.wiff
SA236731	2903	TFA-T19	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T19.wiff
SA236729	3020	TFA-T20	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T20.wiff
SA236730	3021	TFA-T21	F344 Pirc \| Treatment:LD TP-252 (1.5% EPA) \| Metabolite:Fatty Acid \| Tissue:Tumor-adjacent normal colon	TFA-T21.wiff